OPENING REMARKS
- Speaker: Ira Coleman, Chairman, McDermott Will & Emery
COVID-19 IMPACT AND THE ANTICIPATED ROAD TO RECOVERY
- Speaker: Jeff Woods, Managing Director, U.S. Healthcare Practice, EY-Parthenon
THE STATE OF THE HEALTHCARE INDUSTRY
As a healthcare provider or company, what should you do to preserve value, ensure continued operations, negotiate with key stakeholders and evaluate potential financing alternatives or transactions? This panel of leading advisors and bankers, deeply rooted in health business operations across a variety of specialities, will share their observations and effective strategies.
- Moderator: Felicia Perlman, Global Co-Head of Restructuring & Insolvency, McDermott Will & Emery
- Speakers
- Barry Blake, Senior Managing Director, Guggenheim Partners
- Keith Lockwood, Managing Director, Jefferies & Company
- Louis Robichaux IV, Senior Managing Director, Ankura
- Paul Rundell, Managing Director, Alvarez & Marsal
ART OF THE DEAL DURING COVID-19
What do leading investors and advisors see as the short-term and long-term prognosis of buying and selling in the current market? This panel will provide guidance on how to find opportunities and execute deals, including key considerations in evaluating buy-side opportunities and measuring and protecting against downside risk.
- Moderator: Fred Levenson, Global Co-Head of Private Equity, McDermott Will & Emery
- Speakers
- Mark Francis, Managing Director and Head of the Healthcare Group, Houlihan Lokey
- Brad Giordano, Partner, McDermott Will & Emery
- Peter Kaufman, President and Head of Restructuring and Distressed M&A, Gordian Group
- Seth Pearson, Partner, Wellspring Capital Management
- Bob Snape, President, BDO Capital Advisors
CLOSING REMARKS
Speaker: Jerry Sokol, Partner, McDermott Will & Emery
